Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      ES07.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression

      12:02 - 12:14  |  Presenter: Trever Bivona

      • Abstract

      Loading...

    • +

      ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)

      12:14 - 12:26  |  Presenter: Sandra Ortiz-Cuaran

      • Abstract

      Loading...

    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics

      12:38 - 12:50  |  Presenter: Helmut Popper

      • Abstract

      Loading...

    • +

      ES07.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-090 - Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront.

      Presenter: Teresa Gorria

      • Abstract

      Loading...

    • +

      EP08.01-091 - Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone +/- Chemotherapy Upfront

      Presenter: Teresa Gorria

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-016 - Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs

      Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study

      Presenter: Alexander Drilon

      • Abstract

      Loading...

    • +

      EP08.02-173 - Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings

      Presenter: Joshua Sabari

      • Abstract

      Loading...

  • +

    P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      P1.16-02 - Clinical Utility of ctDNA in Advanced NSCLC at Diagnosis or Where Insufficient Tissue Was Available, Based on the ESMO ESCAT Scale

      Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • 08:30 - 10:20
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      PL03.10 - Discussant

      Presenter: Benjamin Besse

      • Abstract

      Loading...

  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • 11:00 - 12:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)

      11:32 - 11:42  |  Presenter: Edouard Auclin

      • Abstract

      Loading...

  • +

    MA07 - Overcoming Resistance to EGFR Inhibitors

    • 12:15 - 13:15
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA

      12:42 - 12:47  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    MA10 - Updates in Thymoma

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)

      15:17 - 15:22  |  Presenter: Jose Carlos Benítez

      • Abstract

      Loading...

  • +

    IS24 - Industry Sponsored Symposium by MSD: New Frontiers in the Management of NSCLC

    • 18:00 - 19:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Industry Symposium
    • Track: N/A
    • +

      IS24.03 - Emergence of Immuno-Oncology in Early-Stage Operable NSCLC

      18:15 - 18:30  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

  • +

    OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Epidemiology
    • +

      OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study

      10:57 - 11:07  |  Presenter: Miguel Garcia Pardo

      • Abstract

      Loading...